+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiopharmaceutical - Global Market Outlook (2019-2027)

  • ID: 5116440
  • Report
  • June 2020
  • Region: Global
  • 185 pages
  • Stratistics Market Research Consulting Pvt Ltd
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Cardinal Health Inc.
  • Curium
  • GE Healthcare
  • JSC Isotope
  • Nordion,Inc.
  • MORE
The Global Radiopharmaceutical market accounted for $3.76 billion in 2019 and is expected to reach $5.99 billion by 2027 growing at a CAGR of 6.0% during the forecast period. Some of the key factors propelling market growth are technological advancements in the diagnostics sector, increasing prevalence of cancer, and increasing applications of molecular imaging. However, the short half-life of radioisotopes is the restraining factor for the growth of the market.

Pharmaceutical formulations that contain radioisotopes are known as radiopharmaceuticals. These are bound with the biological molecules and are targeted for the specific organs. The molecules resulting from these formulations find a wide range of applications in the therapeutic and diagnostic sectors.

By radioisotope, the Technetium-99 segment is expected to grow at a significant market share during the forecast period owing to its easy availability and extensive diagnostic applications. Based on geography, North America is anticipated to hold considerable market share during the forecast period owing to the presence of radioisotope sources in the region.

Some of the key players in Radiopharmaceutical Market include Lantheus Medical Imaging, Inc, GE Healthcare, Advanced Accelerator Applications, Mallinckrodt, Bayer AG, Siemens Healthineers, IBA Radiopharma Solutions, Eckert & Ziegler, Philips, Jubilant Life Sciences Limited, Novartis AG, BWX Technologies, Inc., POLATOM, JSC Isotope, NTP Radioisotopes SOC Ltd, Curium, Australian Nuclear Science and Technology Organization (ANSTO), Cardinal Health Inc., Covidien Plc, Positron Corporation, Monrol Nuclear Products,Inc, and Nordion, Inc.

Sources Covered:
  • Nuclear Reactors
  • Cyclotrons
Types Covered:
  • Therapeutic
  • Diagnostic
Radioisotopes Covered:
  • Yttrium-90
  • Thallium-201
  • Technetium-99
  • Strontium -89
  • Samarium-153
  • Rubidium-82
  • Rhenium-186
  • Radium-223
  • Palladium - 103
  • Leutetium-177
  • Iridium - 192
  • Iodine-131
  • Iodine-125
  • Iodine-123
  • Indium-111
  • Holmium-166
  • Gallium-68
  • Gallium-67
  • Fluorine-18
  • Fludeoxyglucose - (18F-FDG)
  • Erbium-169
  • Cesium-131
  • Actinium-225
Applications Covered:
  • Thyroid
  • Theranostics
  • Oncology
  • Neurology
  • Neuroendocrinology
  • Nephrology
  • Lymphoma
  • Inflammation
  • Gastroenterology
  • Cardiology
End Users Covered:
  • Ambulatory Surgical Centers
  • Cancer Research Institute
  • Diagnostic Imaging Centers
  • Hospitals
Regions Covered:

North America
  • US
  • Canada
  • Mexico
Europe
  • Germany
  • France
  • Italy
  • UK
  • Spain
  • Rest of Europe
Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Rest of Asia Pacific
South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa
What the report offers:
  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company Profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
Free Customization Offerings:

Purchasers of this report will be entitled to receive one of the following free customization options:

1. Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
2. Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
3. Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Cardinal Health Inc.
  • Curium
  • GE Healthcare
  • JSC Isotope
  • Nordion,Inc.
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Radiopharmaceutical Market, By Source
5.1 Introduction
5.2 Nuclear Reactors
5.3 Cyclotrons

6 Global Radiopharmaceutical Market, By Type
6.1 Introduction
6.2 Therapeutic
6.2.1 Alpha Emitters
6.2.2 Beta Emitters
6.2.3 Brachytherapy Isotopes
6.3 Diagnostic
6.3.1 Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals
6.3.2 Positron Emission Tomography (PET) Radiopharmaceuticals

7 Global Radiopharmaceutical Market, By Radioisotope
7.1 Introduction
7.2 Yttrium-90
7.3 Thallium-201
7.4 Technetium-99
7.5 Strontium -89
7.6 Samarium-153
7.7 Rubidium-82
7.8 Rhenium-186
7.9 Radium-223
7.10 Palladium - 103
7.11 Leutetium-177
7.12 Iridium - 192
7.13 Iodine-131
7.14 Iodine-125
7.15 Iodine-123
7.16 Indium-111
7.17 Holmium-166
7.18 Gallium-68
7.19 Gallium-67
7.20 Fluorine-18
7.21 Fludeoxyglucose - (18F-FDG)
7.22 Erbium-169
7.23 Cesium-131

7.24 Actinium-225

8 Global Radiopharmaceutical Market, By Application
8.1 Introduction
8.2 Thyroid
8.3 Theranostics
8.4 Oncology
8.5 Neurology
8.6 Neuroendocrinology
8.7 Nephrology
8.8 Lymphoma
8.9 Inflammation
8.10 Gastroenterology
8.11 Cardiology

9 Global Radiopharmaceutical Market, By End User
9.1 Introduction
9.2 Ambulatory Surgical Centers
9.3 Cancer Research Institute
9.4 Diagnostic Imaging Centers
9.5 Hospitals

10 Global Radiopharmaceutical Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 Lantheus Medical Imaging, Inc
12.2 GE Healthcare
12.3 Advanced Accelerator Applications
12.4 Mallinckrodt
12.5 Bayer AG
12.6 Siemens Healthineers
12.7 IBA Radiopharma Solutions
12.8 Eckert & Ziegler
12.9 Philips
12.10 Jubilant Life Sciences Limited
12.11 Novartis AG
12.12 BWX Technologies, Inc.
12.13 POLATOM
12.14 JSC Isotope
12.15 NTP Radioisotopes SOC Ltd
12.16 Curium
12.17 Australian Nuclear Science and Technology Organization (ANSTO)
12.18 Cardinal Health Inc.
12.19 Covidien Plc
12.20 Positron Corporation
12.21 Monrol Nuclear Products,Inc
12.22 Nordion,Inc.

List of Tables
Table 1 Global Radiopharmaceutical Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Radiopharmaceutical Market Outlook, By Source (2018-2027) ($MN)
Table 3 Global Radiopharmaceutical Market Outlook, By Nuclear Reactors (2018-2027) ($MN)
Table 4 Global Radiopharmaceutical Market Outlook, By Cyclotrons (2018-2027) ($MN)
Table 5 Global Radiopharmaceutical Market Outlook, By Type (2018-2027) ($MN)
Table 6 Global Radiopharmaceutical Market Outlook, By Therapeutic (2018-2027) ($MN)
Table 7 Global Radiopharmaceutical Market Outlook, By Alpha Emitters (2018-2027) ($MN)
Table 8 Global Radiopharmaceutical Market Outlook, By Beta Emitters (2018-2027) ($MN)
Table 9 Global Radiopharmaceutical Market Outlook, By Brachytherapy Isotopes (2018-2027) ($MN)
Table 10 Global Radiopharmaceutical Market Outlook, By Diagnostic (2018-2027) ($MN)
Table 11 Global Radiopharmaceutical Market Outlook, By Single Photon Emission Computed Tomography (SPECT) Radiopharmaceuticals (2018-2027) ($MN)
Table 12 Global Radiopharmaceutical Market Outlook, By Positron Emission Tomography (PET) Radiopharmaceuticals (2018-2027) ($MN)
Table 13 Global Radiopharmaceutical Market Outlook, By Radioisotope (2018-2027) ($MN)
Table 14 Global Radiopharmaceutical Market Outlook, By Yttrium-90 (2018-2027) ($MN)
Table 15 Global Radiopharmaceutical Market Outlook, By Thallium-201 (2018-2027) ($MN)
Table 16 Global Radiopharmaceutical Market Outlook, By Technetium-99 (2018-2027) ($MN)
Table 17 Global Radiopharmaceutical Market Outlook, By Strontium -89 (2018-2027) ($MN)
Table 18 Global Radiopharmaceutical Market Outlook, By Samarium-153 (2018-2027) ($MN)
Table 19 Global Radiopharmaceutical Market Outlook, By Rubidium-82 (2018-2027) ($MN)
Table 20 Global Radiopharmaceutical Market Outlook, By Rhenium-186 (2018-2027) ($MN)
Table 21 Global Radiopharmaceutical Market Outlook, By Radium-223 (2018-2027) ($MN)
Table 22 Global Radiopharmaceutical Market Outlook, By Palladium - 103 (2018-2027) ($MN)
Table 23 Global Radiopharmaceutical Market Outlook, By Leutetium-177 (2018-2027) ($MN)
Table 24 Global Radiopharmaceutical Market Outlook, By Iridium - 192 (2018-2027) ($MN)
Table 25 Global Radiopharmaceutical Market Outlook, By Iodine-131 (2018-2027) ($MN)
Table 26 Global Radiopharmaceutical Market Outlook, By Iodine-125 (2018-2027) ($MN)
Table 27 Global Radiopharmaceutical Market Outlook, By Iodine-123 (2018-2027) ($MN)
Table 28 Global Radiopharmaceutical Market Outlook, By Indium-111 (2018-2027) ($MN)
Table 29 Global Radiopharmaceutical Market Outlook, By Holmium-166 (2018-2027) ($MN)
Table 30 Global Radiopharmaceutical Market Outlook, By Gallium-68 (2018-2027) ($MN)
Table 31 Global Radiopharmaceutical Market Outlook, By Gallium-67 (2018-2027) ($MN)
Table 32 Global Radiopharmaceutical Market Outlook, By Fluorine-18 (2018-2027) ($MN)
Table 33 Global Radiopharmaceutical Market Outlook, By Fludeoxyglucose - (18F-FDG) (2018-2027) ($MN)
Table 34 Global Radiopharmaceutical Market Outlook, By Erbium-169 (2018-2027) ($MN)
Table 35 Global Radiopharmaceutical Market Outlook, By Cesium-131 (2018-2027) ($MN)
Table 36 Global Radiopharmaceutical Market Outlook, By Actinium-225 (2018-2027) ($MN)
Table 37 Global Radiopharmaceutical Market Outlook, By Application (2018-2027) ($MN)
Table 38 Global Radiopharmaceutical Market Outlook, By Thyroid (2018-2027) ($MN)
Table 39 Global Radiopharmaceutical Market Outlook, By Theranostics (2018-2027) ($MN)
Table 40 Global Radiopharmaceutical Market Outlook, By Oncology (2018-2027) ($MN)
Table 41 Global Radiopharmaceutical Market Outlook, By Neurology (2018-2027) ($MN)
Table 42 Global Radiopharmaceutical Market Outlook, By Neuroendocrinology (2018-2027) ($MN)
Table 43 Global Radiopharmaceutical Market Outlook, By Nephrology (2018-2027) ($MN)
Table 44 Global Radiopharmaceutical Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 45 Global Radiopharmaceutical Market Outlook, By Inflammation (2018-2027) ($MN)
Table 46 Global Radiopharmaceutical Market Outlook, By Gastroenterology (2018-2027) ($MN)
Table 47 Global Radiopharmaceutical Market Outlook, By Cardiology (2018-2027) ($MN)
Table 48 Global Radiopharmaceutical Market Outlook, By End User (2018-2027) ($MN)
Table 49 Global Radiopharmaceutical Market Outlook, By Ambulatory Surgical Centers (2018-2027) ($MN)
Table 50 Global Radiopharmaceutical Market Outlook, By Cancer Research Institute (2018-2027) ($MN)
Table 51 Global Radiopharmaceutical Market Outlook, By Diagnostic Imaging Centers (2018-2027) ($MN)
Table 52 Global Radiopharmaceutical Market Outlook, By Hospitals (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Note: Product cover images may vary from those shown
3 of 4
  • Lantheus Medical Imaging, Inc
  • GE Healthcare
  • Advanced Accelerator Applications
  • Mallinckrodt
  • Bayer AG
  • Siemens Healthineers
  • IBA Radiopharma Solutions
  • Eckert & Ziegler
  • Philips
  • Jubilant Life Sciences Limited
  • Novartis AG
  • BWX Technologies, Inc.
  • POLATOM
  • JSC Isotope
  • NTP Radioisotopes SOC Ltd
  • Curium
  • Australian Nuclear Science and Technology Organization (ANSTO)
  • Cardinal Health Inc.
  • Covidien Plc
  • Positron Corporation
  • Monrol Nuclear Products,Inc
  • Nordion,Inc.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll